Reversible Sensorineural Hearing Loss Associated with Off-Label Use of Transcutaneous Vagal Nerve Stimulator

Abstract

Keywords

sensorineural hearing loss (SNHL)transcutaneous vagal nerve stimulation (tVNS)

Get full access to this article

View all access options for this article.

References

Bauer

Baier

Baumgartner

et al . Transcutaneous vagus nerve stimulation (tVNS) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial (cMPsE02). Brain Stimul. 2016;9:356-363.

Vass

Shore

Nuttall

Miller

. Direct evidence of trigeminal innervation of the cochlear blood vessels. Neuroscience. 1998;84:559-567.

Maison

Larsen

et al . Mice lacking adrenergic signaling have normal cochlear responses and normal resistance to acoustic injury but enhanced susceptibility to middle-ear infection. J Assoc Res Otolaryngol. 2010;11:449-461.

Zeng

Djalilian

Lin

. Tinnitus treatment with precise and optimal electric stimulation: opportunities and challenges. Curr Opin Otolaryngol Head Neck Surg. 2015;23:382-387.

Fletcher

. Speech and Hearing in Communication. New York, NY: Van Nostrand; 1953.